Nederlands (Nederland)
AzzavixÂ
Mesalazine, 1000 mg gastro-resistant tabletsNow available
The treatment of the acute phase of mild to moderate ulcerative colitis and the maintenance treatment of remission in ulcerative colitis.
SmPC
Patient information leaflet
Availability and further information?
The product is now available and can be ordered from Fagron.Would you like to know more about using Azzavix for your new or existing patients? Or would you like to get in touch with a Fagron representative? Please do not hesitate to contact us at innovation@fagron.nl or fill in the form.Â
Our pharmacists are ready to help you.
1. Bokemeyer B. Claversal dissolution. Letter to the editor. Aliment Pharmacol Ther. 1999 Sep;13(9):1253. 2. Wilding IR, Behrens C, Tardif SJ, Wray H, Bias P, Albrecht W. Combined scintigraphic and pharmacokinetic investigation of entericcoated mesalazine micropellets in healthy subjects. Clin Exp Gastroenterol. 2003;17(9): 1153-62. 3. Naganuma M. Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis. J Gastroenterol. 2020 Nov;55(11):1013-1022. 4. Tripathi K, Feuerstein JD. Patient preference and adherence to aminosalicylates for the treatment of ulcerative colitis. Clin Exp Gastroenterol. 2021;14:343–351. 5. Azzavix SmPC (januari 2025)
Now available
Azzavix is a gastro-resistant tablet for the treatment of the acute phase of mild to moderate ulcerative colitis and for the maintenance treatment of remission in ulcerative colitis.Availability and further information?
The product is now available and can be ordered from Fagron.Would you like to know more about using Azzavix for your new or existing patients? Or would you like to get in touch with a Fagron representative? Please do not hesitate to contact us at innovation@fagron.nl or fill in the form.Â
Our pharmacists are ready to help you.
1. Bokemeyer B. Claversal dissolution. Letter to the editor. Aliment Pharmacol Ther. 1999 Sep;13(9):1253. 2. Wilding IR, Behrens C, Tardif SJ, Wray H, Bias P, Albrecht W. Combined scintigraphic and pharmacokinetic investigation of entericcoated mesalazine micropellets in healthy subjects. Clin Exp Gastroenterol. 2003;17(9): 1153-62. 3. Naganuma M. Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis. J Gastroenterol. 2020 Nov;55(11):1013-1022. 4. Tripathi K, Feuerstein JD. Patient preference and adherence to aminosalicylates for the treatment of ulcerative colitis. Clin Exp Gastroenterol. 2021;14:343–351. 5. Azzavix SmPC (januari, 2025)